Pharmaceutical Filtration Market 2030: Prefilters Boost Sterile Efficiency

Pharmaceutical Filtration Market Summary

The global pharmaceutical filtration market was valued at USD 11.67 billion in 2022 and is projected to reach USD 21.96 billion by 2030, expanding at a CAGR of 8.03% from 2023 to 2030. Market growth is primarily driven by the rising prevalence of chronic diseases, increasing investments in biopharmaceutical research and development, and continuous technological advancements in sterilization and filtration processes adopted by pharmaceutical and biopharmaceutical manufacturers.

The COVID-19 pandemic had a multifaceted influence on the pharmaceutical filtration market. The surge in demand for vaccines and biologics during the early stages of the pandemic significantly boosted the use of pharmaceutical filtration techniques, as these processes are integral to vaccine and biologics manufacturing. This heightened demand contributed positively to market expansion, reinforcing the critical role of filtration technologies in large-scale pharmaceutical production.

Moreover, the pandemic intensified the focus on safety, quality assurance, and contamination control across pharmaceutical manufacturing operations. As a result, manufacturers increasingly adopted advanced filtration solutions to comply with stringent regulatory requirements. The use of single-use filtration technologies also gained momentum during this period, owing to their ability to minimize cross-contamination risks and improve operational efficiency. These factors collectively supported market growth, despite certain challenges related to supply chain disruptions that caused temporary manufacturing delays and slowed planned drug commercialization activities.

Technological innovation has further strengthened market dynamics. In September 2022, Pall Corporation introduced three new Allegro Connect Systems as part of its single-use filtration portfolio. These systems offer enhanced automation and risk control capabilities, adding value to the production of therapeutic drugs and vaccines. In parallel, the rapid expansion of the biopharmaceutical industry has significantly increased the demand for advanced filtration solutions, particularly in research and manufacturing applications involving large-molecule drugs. Membrane separation processes play a vital role in the development and commercialization of these therapies, thereby reinforcing the need for efficient pharmaceutical filtration technologies.

Order a free sample PDF of the Pharmaceutical Filtration Market Intelligence Study, published by Grand View Research.

Key Market Trends & Insights

• North America dominated the market with a revenue share of 43.23% in 2022.
• The pharmaceutical filtration market in Japan is expected to grow at a notable CAGR from 2024 to 2030.
• By product, the membrane filters segment held the largest market share of 26.08% in 2022.
• By technique, microfiltration accounted for the highest share at 34.41% in 2022.
• By type, the sterile filtration segment dominated the market with a share of 55.79% in 2022.

Market Size & Forecast

• 2022 Market Size: USD 11.67 Billion
• 2030 Projected Market Size: USD 21.96 Billion
• CAGR (2023–2030): 8.03%
• North America: Largest market in 2022

Key Companies & Market Share Insights

The growing demand for pharmaceutical filtration across diverse applications has created substantial opportunities for major industry participants. Leading companies are actively pursuing strategic initiatives such as mergers, acquisitions, and collaborations to strengthen their market presence. For example, in January 2023, Sartorius AG entered into a collaboration with RoosterBio Inc. to provide purification solutions and establish downstream manufacturing processes for exosome-based therapies. Under this agreement, Sartorius AG supplies specialized filtration products to support exosome purification and processing.

Key Pharmaceutical Filtration Companies

• Eaton
• Merck KGaA
• Amazon Filters Ltd.
• Thermo Fisher Scientific Inc.
• Parker Hannifin Corp.
• 3M
• Sartorius AG
• Graver Technologies
• Danaher
• Meissner Filtration Products, Inc.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Conclusion

The pharmaceutical filtration market is poised for sustained growth through 2030, supported by expanding biopharmaceutical manufacturing, rising demand for large-molecule drugs, and increasing emphasis on product safety and quality. Technological advancements, particularly in single-use and membrane-based filtration systems, are further enhancing market prospects. While supply chain disruptions have posed short-term challenges, continued investments in R&D and strategic collaborations are expected to strengthen the long-term outlook of the global pharmaceutical filtration market.